{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:58:27Z","timestamp":1791316707080,"version":"4.3.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2022YFF0705300"],"award-info":[{"award-number":["2022YFF0705300"]}]},{"name":"\u201cYoung Eagle Soaring\u201d Youth Talent Funding Program of Shanghai Pulmonary Hospital","award":["Fkcy2515"],"award-info":[{"award-number":["Fkcy2515"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Increasing evidence has confirmed the existence of resident microbial communities within solid tumors and indicates that the tumor microbiota may represent a novel component of the tumor microenvironment, actively regulating cancer initiation, progression, metastasis, and therapeutic responsiveness. However, the role of tumor microbiota in small cell lung cancer (SCLC) has not been well explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Tumor samples were collected from 71 patients with SCLC at Shanghai Pulmonary Hospital between 2019 and 2023. A comprehensive analysis of the tumor-resident microbiota in SCLC was conducted using 16\u00a0S rRNA sequencing. The bacterial communities were profiled, and their correlation with clinical outcomes was assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 28 phyla, 79 classes, 135 orders, 251 families, and 428 genera were identified, revealing a diverse tumor microbiota in SCLC. It was shown that tumor microbiota varied markedly among patients. SCLC patients with a smoking history exhibited distinct tumor microbiota, with significantly higher abundances of\n                      <jats:italic>Brevundimonas<\/jats:italic>\n                      and\n                      <jats:italic>Gemmatimonadetes<\/jats:italic>\n                      . When patients were stratified by progression-free survival (PFS) into long-PFS (L-PFS) and short-PFS (S-PFS) cohorts, their tumor microbiota segregated distinctly. LEfSe analysis showed that\n                      <jats:italic>Lactobacillus<\/jats:italic>\n                      ,\n                      <jats:italic>Clostridium<\/jats:italic>\n                      ,\n                      <jats:italic>Rothia<\/jats:italic>\n                      , and\n                      <jats:italic>Staphylococcus<\/jats:italic>\n                      were selectively enriched in the L-PFS group, whereas\n                      <jats:italic>Stenotrophomonas<\/jats:italic>\n                      ,\n                      <jats:italic>Cetobacterium<\/jats:italic>\n                      , and\n                      <jats:italic>Aerococcus<\/jats:italic>\n                      dominated the S-PFS group. Kaplan\u2013Meier analysis confirmed that carriage of\n                      <jats:italic>Lactobacillus<\/jats:italic>\n                      ,\n                      <jats:italic>Clostridium<\/jats:italic>\n                      , or\n                      <jats:italic>Staphylococcus<\/jats:italic>\n                      was associated with prolonged survival relative to negative status, while positivity for\n                      <jats:italic>Stenotrophomonas<\/jats:italic>\n                      ,\n                      <jats:italic>Cetobacterium<\/jats:italic>\n                      , or\n                      <jats:italic>Aerococcus<\/jats:italic>\n                      conferred a reduction in survival. Subsequent response-stratified analysis revealed that\n                      <jats:italic>Clostridium<\/jats:italic>\n                      - and\n                      <jats:italic>Lactobacillus<\/jats:italic>\n                      -positive SCLC was associated with a significantly higher response rate. Conversely, positivity for\n                      <jats:italic>Methylobacterium<\/jats:italic>\n                      ,\n                      <jats:italic>Pelomonas<\/jats:italic>\n                      ,\n                      <jats:italic>Ralstonia<\/jats:italic>\n                      ,\n                      <jats:italic>Bradyrhizobium<\/jats:italic>\n                      ,\n                      <jats:italic>Variovorax<\/jats:italic>\n                      ,\n                      <jats:italic>Microbacterium<\/jats:italic>\n                      ,\n                      <jats:italic>Comamonas<\/jats:italic>\n                      , or\n                      <jats:italic>Sphingomonas<\/jats:italic>\n                      markedly reduced response. The intersection of survival and response results identify\n                      <jats:italic>Clostridium<\/jats:italic>\n                      and\n                      <jats:italic>Lactobacillus<\/jats:italic>\n                      as promising prognostic tumor microbiota markers in SCLC. In vitro assays demonstrated that the\n                      <jats:italic>Clostridium<\/jats:italic>\n                      and\n                      <jats:italic>Lactobacillus<\/jats:italic>\n                      metabolites, butyrate and lactic acid, lacked direct cytotoxicity against SCLC cells. However, in the syngeneic mouse model, systemic supplementation of butyrate or lactic acid significantly potentiated the anti-tumor efficacy of standard chemotherapy. Notably, flow cytometric analysis revealed that this in vivo synergistic effect was closely associated with a profound increase in CD8\u2009+\u2009T cell infiltration within the tumor microenvironment. Furthermore, integrating these two tumor microbiota with key clinical variables (sex, age, smoking, stage, radiotherapy), we constructed three models\u2014therapeutic-response, 1-year PFS, and 1-year overall survival\u2014that maintained robust performance in both training and validation cohorts.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      In conclusion, the tumor-resident microbiota constitutes a critical component of the SCLC tumor microenvironment, exerting profound influence on the therapeutic response and patient prognosis. In detail,\n                      <jats:italic>Clostridium<\/jats:italic>\n                      and\n                      <jats:italic>Lactobacillus<\/jats:italic>\n                      \u2014two pivotal tumor-resident taxa significantly linked to enhanced therapeutic responses and favorable prognosis\u2014indicate their potential as predictive biomarkers for treatment outcomes and patient prognosis, and highlight them as candidate targets for microbiome-directed therapeutic strategies against SCLC, which warrants further functional validation.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-026-08109-x","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T14:18:56Z","timestamp":1776176336000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Profiling the tumor-resident microbiota in small cell lung cancer and its influence on clinical outcomes"],"prefix":"10.1186","volume":"24","author":[{"given":"Wengang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huixian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runze","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2878-8595","authenticated-orcid":false,"given":"Yayi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"8109_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","volume":"7","author":"CM Rudin","year":"2021","unstructured":"Rudin CM, Brambilla E, Faivre-Finn C, et al. Small-cell lung cancer. Nat Rev Dis Primers. 2021;7:3.","journal-title":"Nat Rev Dis Primers"},{"key":"8109_CR2","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jtho.2015.10.008","volume":"11","author":"AG Nicholson","year":"2016","unstructured":"Nicholson AG, Chansky K, Crowley J, et al. The international association for the study of lung cancer lung cancer staging project: proposals for the revision of the clinical and pathologic staging of small cell lung cancer in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11:300\u201311.","journal-title":"J Thorac Oncol"},{"key":"8109_CR3","doi-asserted-by":"publisher","first-page":"e35770","DOI":"10.1002\/cncr.35770","volume":"131","author":"MD Shields","year":"2025","unstructured":"Shields MD, Chiang AC, Byers LA. Top advances of the year: small cell lung cancer. Cancer. 2025;131:e35770.","journal-title":"Cancer"},{"key":"8109_CR4","doi-asserted-by":"crossref","unstructured":"Ashrafi A, Akter Z, Modareszadeh P, et al. Current landscape of therapeutic resistance in lung cancer and promising strategies to overcome resistance. Cancers (Basel). 2022;14.","DOI":"10.3390\/cancers14194562"},{"key":"8109_CR5","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1001\/jama.2025.0560","volume":"333","author":"SY Kim","year":"2025","unstructured":"Kim SY, Park HS, Chiang AC. Small cell lung cancer: a review. JAMA. 2025;333:1906\u201317.","journal-title":"JAMA"},{"key":"8109_CR6","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41568-025-00803-0","volume":"25","author":"KL Simpson","year":"2025","unstructured":"Simpson KL, Rothwell DG, Blackhall F, et al. Challenges of small cell lung cancer heterogeneity and phenotypic plasticity. Nat Rev Cancer. 2025;25:447\u201362.","journal-title":"Nat Rev Cancer"},{"key":"8109_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13045-025-01722-1","volume":"18","author":"X Cheng","year":"2025","unstructured":"Cheng X, Peng T, Chu T, et al. Application of single-cell and spatial omics in deciphering cellular hallmarks of cancer drug response and resistance. J Hematol Oncol. 2025;18:70.","journal-title":"J Hematol Oncol"},{"key":"8109_CR8","doi-asserted-by":"crossref","unstructured":"Ge M, Chen XY, Huang P, et al. Understanding and overcoming multidrug resistance in cancer. Nat Rev Clin Oncol. 2025.","DOI":"10.1038\/s41571-025-01059-1"},{"key":"8109_CR9","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA. The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41:374\u2013403.","journal-title":"Cancer Cell"},{"key":"8109_CR10","doi-asserted-by":"publisher","first-page":"188997","DOI":"10.1016\/j.bbcan.2023.188997","volume":"1878","author":"Z Li","year":"2023","unstructured":"Li Z, Yin P. Tumor microenvironment diversity and plasticity in cancer multidrug resistance. Biochim Biophys Acta Rev Cancer. 2023;1878:188997.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"8109_CR11","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.aay9189","volume":"368","author":"D Nejman","year":"2020","unstructured":"Nejman D, Livyatan I, Fuks G, et al. The human tumor microbiome is composed of tumor type-specific intracellular bacteria. Science. 2020;368:973\u201380.","journal-title":"Science"},{"key":"8109_CR12","first-page":"38","volume":"12","author":"YC Luo","year":"2025","unstructured":"Luo YC, Huang XT, Wang R, et al. Advancements in understanding tumor-resident bacteria and their application in cancer therapy. Mil Med Res. 2025;12:38.","journal-title":"Mil Med Res"},{"key":"8109_CR13","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.cell.2024.03.021","volume":"187","author":"TW Battaglia","year":"2024","unstructured":"Battaglia TW, Mimpen IL, Traets JJH, et al. A pan-cancer analysis of the microbiome in metastatic cancer. Cell. 2024;187:2324\u201335. e19.","journal-title":"Cell"},{"key":"8109_CR14","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41586-022-05435-0","volume":"611","author":"JL Galeano Nino","year":"2022","unstructured":"Galeano Nino JL, Wu H, LaCourse KD, et al. Effect of the intratumoral microbiota on spatial and cellular heterogeneity in cancer. Nature. 2022;611:810\u20137.","journal-title":"Nature"},{"key":"8109_CR15","doi-asserted-by":"crossref","unstructured":"Fu A, Yao B, Dong T, et al. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer. Cell. 2022;185:1356\u201372 e26.","DOI":"10.1016\/j.cell.2022.02.027"},{"key":"8109_CR16","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/s43018-022-00358-1","volume":"3","author":"C Guo","year":"2022","unstructured":"Guo C, Wan R, He Y, et al. Therapeutic targeting of the mevalonate-geranylgeranyl diphosphate pathway with statins overcomes chemotherapy resistance in small cell lung cancer. Nat Cancer. 2022;3:614\u201328.","journal-title":"Nat Cancer"},{"key":"8109_CR17","doi-asserted-by":"publisher","first-page":"2300846","DOI":"10.1080\/19490976.2023.2300846","volume":"16","author":"SY Lee","year":"2024","unstructured":"Lee SY, Jhun J, Woo JS, et al. Gut microbiome-derived butyrate inhibits the immunosuppressive factors PD-L1 and IL-10 in tumor-associated macrophages in gastric cancer. Gut Microbes. 2024;16:2300846.","journal-title":"Gut Microbes"},{"key":"8109_CR18","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.1038\/s41467-022-32521-8","volume":"13","author":"Q Feng","year":"2022","unstructured":"Feng Q, Liu Z, Yu X, et al. Lactate increases stemness of CD8\u2009+\u2009T cells to augment anti-tumor immunity. Nat Commun. 2022;13:4981.","journal-title":"Nat Commun"},{"key":"8109_CR19","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41586-019-1608-2","volume":"574","author":"B Aykut","year":"2019","unstructured":"Aykut B, Pushalkar S, Chen R, et al. The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL. Nature. 2019;574:264\u20137.","journal-title":"Nature"},{"key":"8109_CR20","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.tcb.2022.11.007","volume":"33","author":"A Fu","year":"2023","unstructured":"Fu A, Yao B, Dong T, et al. Emerging roles of intratumor microbiota in cancer metastasis. Trends Cell Biol. 2023;33:583\u201393.","journal-title":"Trends Cell Biol"},{"key":"8109_CR21","first-page":"e20210185","volume":"5","author":"Y Niu","year":"2025","unstructured":"Niu Y, Feng J, Ma J, et al. Targeting the tumor microbiota in cancer therapy basing on nanomaterials. Explor (Beijing). 2025;5:e20210185.","journal-title":"Explor (Beijing)"},{"key":"8109_CR22","doi-asserted-by":"crossref","unstructured":"Boesch M, Horvath L, Baty F, et al. Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospects. J Immunother Cancer. 2022;10.","DOI":"10.1136\/jitc-2022-005401"},{"key":"8109_CR23","doi-asserted-by":"publisher","first-page":"e232","DOI":"10.1002\/imt2.232","volume":"3","author":"B Li","year":"2024","unstructured":"Li B, Wang D, Zhang C, et al. Role of respiratory system microbiota in development of lung cancer and clinical application. Imeta. 2024;3:e232.","journal-title":"Imeta"},{"key":"8109_CR24","doi-asserted-by":"publisher","first-page":"e70156","DOI":"10.1002\/ctm2.70156","volume":"15","author":"F Mao","year":"2025","unstructured":"Mao F, Hu Z, Shi R, et al. Unravelling the prognostic and operative role of intratumoural microbiota in non-small cell lung cancer: Insights from 16S rRNA and RNA sequencing. Clin Transl Med. 2025;15:e70156.","journal-title":"Clin Transl Med"},{"key":"8109_CR25","doi-asserted-by":"publisher","first-page":"101488","DOI":"10.1016\/j.xcrm.2024.101488","volume":"5","author":"Y Ma","year":"2024","unstructured":"Ma Y, Chen H, Li H, et al. Intratumor microbiome-derived butyrate promotes lung cancer metastasis. Cell Rep Med. 2024;5:101488.","journal-title":"Cell Rep Med"},{"key":"8109_CR26","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41597-024-03210-6","volume":"11","author":"RO Jensen","year":"2024","unstructured":"Jensen RO, Schulz F, Roux S, et al. Phylogenomics and genetic analysis of solvent-producing Clostridium species. Sci Data. 2024;11:432.","journal-title":"Sci Data"},{"key":"8109_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1907272","volume":"13","author":"MK Stoeva","year":"2021","unstructured":"Stoeva MK, Garcia-So J, Justice N, et al. Butyrate-producing human gut symbiont, Clostridium butyricum, and its role in health and disease. Gut Microbes. 2021;13:1\u201328.","journal-title":"Gut Microbes"},{"key":"8109_CR28","doi-asserted-by":"crossref","unstructured":"Montalban-Arques A, Katkeviciute E, Busenhart P, et al. Commensal Clostridiales strains mediate effective anti-cancer immune response against solid tumors. Cell Host Microbe. 2021;29:1573\u201388 e7.","DOI":"10.1016\/j.chom.2021.08.001"},{"key":"8109_CR29","doi-asserted-by":"crossref","unstructured":"Xie M, Yuan K, Zhang Y, et al. Tumor-resident probiotic clostridium butyricum improves aPD-1 efficacy in colorectal cancer models by inhibiting IL-6-mediated immunosuppression. Cancer Cell. 2025.","DOI":"10.1016\/j.ccell.2025.07.012"},{"key":"8109_CR30","doi-asserted-by":"publisher","first-page":"2186114","DOI":"10.1080\/19490976.2023.2186114","volume":"15","author":"H Xu","year":"2023","unstructured":"Xu H, Luo H, Zhang J, et al. Therapeutic potential of clostridium butyricum anticancer effects in colorectal cancer. Gut Microbes. 2023;15:2186114.","journal-title":"Gut Microbes"},{"key":"8109_CR31","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3892\/ol.2020.12371","volume":"21","author":"X Feng","year":"2021","unstructured":"Feng X, He P, Zeng C, et al. Novel insights into the role of Clostridium novyi-NT related combination bacteriolytic therapy in solid tumors. Oncol Lett. 2021;21:110.","journal-title":"Oncol Lett"},{"key":"8109_CR32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1158\/1078-0432.CCR-20-2065","volume":"27","author":"F Janku","year":"2021","unstructured":"Janku F, Zhang HH, Pezeshki A, et al. Intratumoral Injection of clostridium novyi-NT spores in patients with treatment-refractory advanced solid tumors. Clin Cancer Res. 2021;27:96\u2013106.","journal-title":"Clin Cancer Res"},{"key":"8109_CR33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s40291-024-00695-0","volume":"28","author":"J Theys","year":"2024","unstructured":"Theys J, Patterson AV, Mowday AM. Clostridium bacteria: harnessing tumour necrosis for targeted gene delivery. Mol Diagn Ther. 2024;28:141\u201351.","journal-title":"Mol Diagn Ther"},{"key":"8109_CR34","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1038\/s41467-021-24331-1","volume":"12","author":"M Luu","year":"2021","unstructured":"Luu M, Riester Z, Baldrich A, et al. Microbial short-chain fatty acids modulate CD8(+) T cell responses and improve adoptive immunotherapy for cancer. Nat Commun. 2021;12:4077.","journal-title":"Nat Commun"},{"key":"8109_CR35","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s42003-025-07856-9","volume":"8","author":"M Xie","year":"2025","unstructured":"Xie M, Yang T, Liu Q, et al. The influence of Lactobacillus johnsonii on tumor growth and lymph node metastasis in papillary thyroid carcinoma. Commun Biol. 2025;8:419.","journal-title":"Commun Biol"},{"key":"8109_CR36","doi-asserted-by":"publisher","first-page":"e70050","DOI":"10.1002\/imo2.70050","volume":"2","author":"W Lyu","year":"2025","unstructured":"Lyu W, Chen L, Li D-F, et al. Lactobacillus johnsonii-FM1 modulates gut microbiota and secretes anticancer metabolite vanillic acid to inhibit colorectal tumorigenesis. iMetaOmics. 2025;2:e70050.","journal-title":"iMetaOmics"},{"key":"8109_CR37","doi-asserted-by":"publisher","first-page":"2449111","DOI":"10.1080\/19490976.2024.2449111","volume":"17","author":"Y Sun","year":"2025","unstructured":"Sun Y, Wang Q, Jiang Y, et al. Lactobacillus intestinalis facilitates tumor-derived CCL5 to recruit dendritic cell and suppress colorectal tumorigenesis. Gut Microbes. 2025;17:2449111.","journal-title":"Gut Microbes"},{"key":"8109_CR38","doi-asserted-by":"crossref","unstructured":"Colbert LE, El Alam MB, Wang R, et al. Tumor-resident Lactobacillus iners confer chemoradiation resistance through lactate-induced metabolic rewiring. Cancer Cell. 2023;41:1945\u201362 e11.","DOI":"10.1016\/j.ccell.2023.09.012"},{"key":"8109_CR39","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1136\/gutjnl-2021-325021","volume":"71","author":"X Bai","year":"2022","unstructured":"Bai X, Wei H, Liu W, et al. Cigarette smoke promotes colorectal cancer through modulation of gut microbiota and related metabolites. Gut. 2022;71:2439\u201350.","journal-title":"Gut"},{"key":"8109_CR40","doi-asserted-by":"publisher","first-page":"100884","DOI":"10.1016\/j.xcrm.2022.100884","volume":"4","author":"C Xue","year":"2023","unstructured":"Xue C, Chu Q, Zheng Q, et al. Current understanding of the intratumoral microbiome in various tumors. Cell Rep Med. 2023;4:100884.","journal-title":"Cell Rep Med"},{"key":"8109_CR41","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13059-018-1501-6","volume":"19","author":"KL Greathouse","year":"2018","unstructured":"Greathouse KL, White JR, Vargas AJ, et al. Interaction between the microbiome and TP53 in human lung cancer. Genome Biol. 2018;19:123.","journal-title":"Genome Biol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08109-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08109-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08109-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:02:32Z","timestamp":1781647352000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08109-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8109"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08109-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"28 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Research Ethics Committee of Shanghai Pulmonary Hospital, and informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors declare no financial or non-financial competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"537"}}